{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04977453",
            "orgStudyIdInfo": {
                "id": "GII-101-P101 (MK-3475-B59)"
            },
            "secondaryIdInfos": [
                {
                    "id": "KEYNOTE-B59",
                    "type": "OTHER",
                    "domain": "Merck Sharpe and Dohme LLC"
                }
            ],
            "organization": {
                "fullName": "GI Innovation, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors",
            "officialTitle": "A Phase 1/2, Open-label, Dose-escalation, and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Therapeutic Activity of GI-101 as a Single Agent and in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Patients With Advanced or Metastatic Solid Tumors (Keynote B59)",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "gi-as-a-single-agent-or-in-combination-with-pembrolizumab-lenvatinib-or-local-radiotherapy-in-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-07-09",
            "studyFirstSubmitQcDate": "2021-07-26",
            "studyFirstPostDateStruct": {
                "date": "2021-07-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-20",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "GI Innovation, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Merck Sharp & Dohme LLC",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-101/GI-101A as a single agent or in combination with pembrolizumab, lenvatinib or local radiotherapy (RT) over a range of advanced and/or metastatic solid tumors.",
            "detailedDescription": "This is a phase 1/2, open-label, dose-escalation and expansion study to evaluate the safety, tolerability and anti-tumor effect of GI-101/GI-101A as a single agent or in combination with pembrolizumab, lenvatinib or local RT over a range of advanced and/or metastatic solid tumors.\n\nThis study will comprise six parts.\n\n* Part A: Dose-escalation and expansion cohorts of GI-101 monotherapy\n* Part B: Dose-escalation and expansion cohorts of GI-101 plus pembrolizumab\n* Part C: Dose-optimization and expansion cohorts of GI-101 plus lenvatinib\n* Part D: Dose-optimization and expansion cohorts of GI-101 plus local RT\n* Part E: Dose-escalation and expansion cohorts of GI-101A monotherapy\n* Part F: Dose-escalation and expansion cohorts of GI-101A plus pembrolizumab\n\nGI-101/GI-101A is a novel bi-specific Fc fusion protein containing the CD80 ectodomain as an N-terminal moiety and an interleukin (IL)-2 variant as a C-terminal moiety configurated via a human immunoglobulin G4 (IgG4) Fc.\n\nGI-101A is an abbreviation of advanced GI-101 with an improved formulation for manufacture consistency.\n\nDrug Information available for: Pembrolizumab (https://www.keytrudahcp.com), Lenvatinib (http://www.lenvima.com)"
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Solid Tumor",
                "Metastatic Solid Tumor",
                "Non-small Cell Lung Cancer",
                "Head and Neck Squamous Cell Carcinoma",
                "Renal Cell Carcinoma",
                "Urinary Bladder Cancer",
                "Melanoma",
                "Sarcoma",
                "Microsatellite Stable Colorectal Carcinoma",
                "Merkel Cell Carcinoma",
                "Esophageal Squamous Cell Carcinoma",
                "Cervical Cancer",
                "Vaginal Cancer",
                "Vulvar Cancer"
            ],
            "keywords": [
                "GI-101/GI-101A",
                "CD80-IgG4 Fc-IL2 variant",
                "Immunotherapy",
                "IL-2",
                "Interleukin-2",
                "Pembrolizumab",
                "Lenvatinib",
                "Radiotherapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 430,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "GI-101",
                    "type": "EXPERIMENTAL",
                    "description": "Dose escalation: GI-101, multiple ascending doses\n\nDose expansion:",
                    "interventionNames": [
                        "Drug: GI-101"
                    ]
                },
                {
                    "label": "GI-101 + Pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Dose escalation: GI-101, multiple ascending doses\n\nDose expansion:",
                    "interventionNames": [
                        "Drug: GI-101",
                        "Drug: Pembrolizumab (KEYTRUDA\u00ae)"
                    ]
                },
                {
                    "label": "GI-101 + Lenvatinib",
                    "type": "EXPERIMENTAL",
                    "description": "Dose optimization:\n\nDose expansion:",
                    "interventionNames": [
                        "Drug: GI-101",
                        "Drug: Lenvatinib"
                    ]
                },
                {
                    "label": "GI-101 + Local Radiotherapy",
                    "type": "EXPERIMENTAL",
                    "description": "Dose optimization:\n\nDose expansion:",
                    "interventionNames": [
                        "Drug: GI-101",
                        "Radiation: Local Radiotherapy"
                    ]
                },
                {
                    "label": "GI-101A",
                    "type": "EXPERIMENTAL",
                    "description": "Dose escalation: GI-101A, multiple ascending doses\n\nDose expansion:",
                    "interventionNames": [
                        "Drug: GI-101A"
                    ]
                },
                {
                    "label": "GI-101A + Pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Dose escalation: GI-101A, multiple ascending doses\n\nDose expansion:",
                    "interventionNames": [
                        "Drug: Pembrolizumab (KEYTRUDA\u00ae)",
                        "Drug: GI-101A"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "GI-101",
                    "description": "Recommended phase 2 dose of GI-101 will be administered via IV infusion Q3W up to 2 years (approximately 35 years).",
                    "armGroupLabels": [
                        "GI-101",
                        "GI-101 + Lenvatinib",
                        "GI-101 + Local Radiotherapy",
                        "GI-101 + Pembrolizumab"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pembrolizumab (KEYTRUDA\u00ae)",
                    "description": "Pembrolizumab will be administered at a dose of 200 mg as IV infusion Q3W.",
                    "armGroupLabels": [
                        "GI-101 + Pembrolizumab",
                        "GI-101A + Pembrolizumab"
                    ],
                    "otherNames": [
                        "KEYTRUDA\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lenvatinib",
                    "description": "Lenvatinib will be administered at an approved dose orally.",
                    "armGroupLabels": [
                        "GI-101 + Lenvatinib"
                    ],
                    "otherNames": [
                        "Lenvima\u00ae"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Local Radiotherapy",
                    "description": "Patients will receive SBRT prior to the first dose of GI-101",
                    "armGroupLabels": [
                        "GI-101 + Local Radiotherapy"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "GI-101A",
                    "description": "Recommended phase 2 dose of GI-101A will be administered via IV infusion Q3W up to 2 years (approximately 35 years).",
                    "armGroupLabels": [
                        "GI-101A",
                        "GI-101A + Pembrolizumab"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence and nature of Dose-Limiting Toxicity (DLTs)",
                    "description": "Based on toxicities observed.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Incidence, nature, and severity of adverse events (AEs) and immune-related AEs (irAEs)",
                    "description": "Based on toxicities observed.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Objective Response Rate (ORR) according to RECIST version 1.1",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Peak plasma concentration (Cmax) of GI-101/GI-101A",
                    "description": "Based on the concentration vs time profile by dose level",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Half-life of GI-101/GI-101A (T1/2)",
                    "description": "Based on the concentration vs time profile by dose level",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Area under the plasma concentration versus time curve (AUC) of GI-101/GI-101A",
                    "description": "Based on the concentration vs time profile by dose level",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Disease control rate (DCR) according to RECIST version 1.1",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Duration of objective Response (DoR) according to RECIST version 1.1",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Time to Tumor Response (TTR) according to RECIST version 1.1",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Progression-Free Survival (PFS) according to RECIST version 1.1",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "ORR per iRECIST guidelines",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "DCR per iRECIST guidelines",
                    "description": "Based on Investigator review of radiographic imaging.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Incidence of anti-GI-101/GI-101A antibody (ADA) and neutralizing antibody (Nab)",
                    "description": "Serum will be assessed for the presence of ADA and Nab based on the appropriate assay.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                },
                {
                    "measure": "Immunophenotyping of peripheral blood mononuclear cells will be performed by flow cytometry at various time points",
                    "description": "Peripheral immune cell subpopulation (e.g., CD4+ T cells, CD8+ T cells, regulatory T cells) will be assessed.",
                    "timeFrame": "Study Day 1, assessed up to approximately 24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Males and females aged \u2265 18 years (or \u2265 19 years according to local regulatory guidelines) at the time of screening.\n* Has adequate organ and marrow function as defined in protocol.\n* Measurable disease as per RECIST v1.1.\n* ECOG performance status 0-1.\n* Adverse events related to any prior chemotherapy, radiotherapy, immunotherapy, other prior systemic anti-cancer therapy, or surgery must have resolved to Grade \u22641, except alopecia and Grade 2 peripheral neuropathy.\n* HIV infected patients must be on anti-retroviral therapy (ART) and have a well-controlled HIV infection/disease as defined in protocol.\n\nKey Exclusion Criteria:\n\n* Has known active CNS metastases and/or carcinomatous meningitis.\n* An active second malignancy\n* Has active or a known history of Hepatitis B or known active Hepatitis C virus infection.\n* Has active tuberculosis or has a known history of active tuberculosis\n* Active or uncontrolled infections, or severe infection within 4 weeks before study treatment administration.\n* History of chronic liver disease or evidence of hepatic cirrhosis, except patients with liver metastasis.\n* Has an active autoimmune disease that has required systemic treatment in past 2 years.\n* Previous immunotherapies related to mode of action of GI-101.\n* Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy or any other form of immunosuppressive medications within 2 weeks prior to Cycle 1 Day 1.\n* Administration of prior systemic anti-cancer therapy including investigational agents within 4 weeks prior to treatment.\n* Radiotherapy within the last 2 weeks before start of study treatment administration, with exception of limited field palliative radiotherapy (except Part D).\n* Administration of a live, attenuated vaccine within 4 weeks before Cycle 1 Day 1.\n* Known hypersensitivity to any of the components of the drug products and/or excipients of GI-101, pembrolizumab or lenvatinib.\n\nOther protocol defined inclusion exclusion criteria may apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Recruiting sites have contact information. Please contact the sites directly.",
                    "role": "CONTACT",
                    "phone": "+82-2-404-2003",
                    "email": "clinical@gi-innovation.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Nari Yun, PhD",
                    "affiliation": "GI Innovation",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Tisch Cancer Institute (TCI), Icahn School of Medicine",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10029-5674",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Thomas Marron, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Carolina Biooncology Institute",
                    "status": "RECRUITING",
                    "city": "Huntersville",
                    "state": "North Carolina",
                    "zip": "28078",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John Powderly, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.41069,
                        "lon": -80.84285
                    }
                },
                {
                    "facility": "The Catholic University of Korea St. Vincent's Hospital",
                    "status": "RECRUITING",
                    "city": "Suwon-si",
                    "state": "Kyeonggi-do",
                    "zip": "16247",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Byoung-Yong Shim, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.29111,
                        "lon": 127.00889
                    }
                },
                {
                    "facility": "Korea University Anam Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seongbuk-gu",
                    "zip": "02841",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Soohyeon Lee, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Chungnam National University Hospital",
                    "status": "RECRUITING",
                    "city": "Daejeon",
                    "zip": "65015",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "HyoJin Lee, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.32139,
                        "lon": 127.41972
                    }
                },
                {
                    "facility": "Yonsei University Health System, Severance Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Byoung Chul Cho, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Sang Joon Shin, M.D., Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Yonsei University Health System, Severance Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Jung-Yun Lee, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Asan Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Jae Lyun Lee, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015266",
                    "term": "Carcinoma, Merkel Cell"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                },
                {
                    "id": "D000077277",
                    "term": "Esophageal Squamous Cell Carcinoma"
                },
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                },
                {
                    "id": "D000014846",
                    "term": "Vulvar Neoplasms"
                },
                {
                    "id": "D000014625",
                    "term": "Vaginal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000012002",
                    "term": "Rectal Diseases"
                },
                {
                    "id": "D000014845",
                    "term": "Vulvar Diseases"
                },
                {
                    "id": "D000027601",
                    "term": "Polyomavirus Infections"
                },
                {
                    "id": "D000004266",
                    "term": "DNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000014412",
                    "term": "Tumor Virus Infections"
                },
                {
                    "id": "D000018278",
                    "term": "Carcinoma, Neuroendocrine"
                },
                {
                    "id": "D000014623",
                    "term": "Vaginal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Urinary Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5830",
                    "name": "Uterine Cervical Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15327",
                    "name": "Sarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5548",
                    "name": "Carcinoma, Renal Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M17373",
                    "name": "Vaginal Neoplasms",
                    "asFound": "Vaginal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1733",
                    "name": "Esophageal Squamous Cell Carcinoma",
                    "asFound": "Esophageal Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17589",
                    "name": "Vulvar Neoplasms",
                    "asFound": "Vulvar Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17967",
                    "name": "Carcinoma, Merkel Cell",
                    "asFound": "Merkel Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Head and Neck Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "asFound": "Colorectal Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14844",
                    "name": "Rectal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17588",
                    "name": "Vulvar Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23236",
                    "name": "Polyomavirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7442",
                    "name": "DNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17162",
                    "name": "Tumor Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M20423",
                    "name": "Carcinoma, Neuroendocrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M17371",
                    "name": "Vaginal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5284",
                    "name": "Soft Tissue Sarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4906",
                    "name": "Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1341",
                    "name": "Clear Cell Renal Cell Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T5829",
                    "name": "Vaginal Cancer",
                    "asFound": "Vaginal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5877",
                    "name": "Vulvar Cancer",
                    "asFound": "Vulvar Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3716",
                    "name": "Merkel Cell Carcinoma",
                    "asFound": "Merkel Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "C000531958",
                    "term": "Lenvatinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Screening",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M353738",
                    "name": "Lenvatinib",
                    "asFound": "Approved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10411",
                    "name": "Interleukin-2",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                }
            ]
        }
    },
    "hasResults": false
}